Learn about the Prescribed List
Find out about the list, its use and related legislation.
What we're doing
Read about the policies we've developed and consultations we undertake.
Health Products Portal
Sponsors can use the portal to apply to list a product, or manage existing products.
The Prescribed List
Latest version of the list.
Prescribed List Guide
Draft guidelines to help you with your application.
PHI circulars
Read the latest private health insurance circulars for updates on matters affecting private health insurers.
Related committees and groups
Medical Devices and Human Tissue Advisory Committee (MDHTAC)
MDHTAC provides recommendations and advice about the listing of products on the Prescribed List and benefits payable by private health insurers.
Expert Clinical Advisory Groups (ECAGs)
The Expert Clinical Advisory Groups (ECAGs) are subcommittees that assess and advise the MDHTAC and us on the suitability of products for listing, or listed on, the Prescribed List.
Latest resources
Latest resources
Prescribed List of Medical Devices and Human Tissue Products
This page lists the medical devices and human tissue products private health insurers must pay benefits for to the patients who have appropriate insurance policies. The latest version of the Prescribed List is effective from 1 November 2025.
PL reforms – summary of objectives and achievements
The Prescribed List reforms finished in June 2025. This document list the reforms objectives and achievements.
Interim Evaluation #2 of the Prescribed List Reforms
This interim evaluation report 2 covers the period from July 2024 to June 2025. It builds on the interim evaluation report 1.
Prescribed List Post-Listing review – Consultants report
This report informs stage 2 of the post-listing review of surgical guides and biomodels.
Date last updated: